Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Cornblath

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Journal of the Peripheral Nervous System : JPNS|March 13, 2016
Does ability to walk reflect general functionality in inflammatory neuropathies?Thomas H P Draak, Kenneth C Gorson, Els K Vanhoutte, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra studyOrell Mielke, Vera Bril, David R Cornblath, et al.
The Lancet. Neurology|November 11, 2017
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialIvo N van Schaik, Vera Bril, Nan van Geloven, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 30, 2019
Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension studyIvo N van Schaik, Orell Mielke, Vera Bril, et al.
Journal of the Peripheral Nervous System : JPNS|September 23, 2025
Rasch-Built Overall Disability Scale for IgM-Associated Polyneuropathy With and Without Anti-MAG Antibodies: IgM-RODSTatiana Hamadeh, Johannes P M van de Mortel, Janneke G J Hoeijmakers, et al.
Journal of the Peripheral Nervous System : JPNS|April 14, 2017
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndromeBart C Jacobs, Bianca van den Berg, Christine Verboon, et al.
Neurology|June 9, 2019
Current treatment practice of Guillain-Barré syndromeChristine Verboon, Alex Y Doets, Giuliana Galassi, et al.
Journal of the Peripheral Nervous System : JPNS|September 3, 2015
Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS(©) )Els K Vanhoutte, Catharina G Faber, Sonja I van Nes, et al.
Journal of Neurology|February 25, 2026
Measurement properties of the Inflammatory Rasch-built Overall Disability Scale (I-RODS) in patients with Guillain-Barré syndromeFarah Pelouto, Nowshin Papri, Juanita A Haagsma, et al.
Journal of the Peripheral Nervous System : JPNS|April 12, 2023
IgM anti-MAG<sup>±</sup> peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M-protein peripheral neuropathiesTatiana Hamadeh, Perry T C van Doormaal, Mariëlle H J Pruppers, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Journal of the Peripheral Nervous System : JPNS|March 13, 2016
Does ability to walk reflect general functionality in inflammatory neuropathies?Thomas H P Draak, Kenneth C Gorson, Els K Vanhoutte, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra studyOrell Mielke, Vera Bril, David R Cornblath, et al.
The Lancet. Neurology|November 11, 2017
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialIvo N van Schaik, Vera Bril, Nan van Geloven, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 30, 2019
Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension studyIvo N van Schaik, Orell Mielke, Vera Bril, et al.
Journal of the Peripheral Nervous System : JPNS|September 23, 2025
Rasch-Built Overall Disability Scale for IgM-Associated Polyneuropathy With and Without Anti-MAG Antibodies: IgM-RODSTatiana Hamadeh, Johannes P M van de Mortel, Janneke G J Hoeijmakers, et al.
Journal of the Peripheral Nervous System : JPNS|April 14, 2017
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndromeBart C Jacobs, Bianca van den Berg, Christine Verboon, et al.
Neurology|June 9, 2019
Current treatment practice of Guillain-Barré syndromeChristine Verboon, Alex Y Doets, Giuliana Galassi, et al.
Journal of the Peripheral Nervous System : JPNS|September 3, 2015
Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS(©) )Els K Vanhoutte, Catharina G Faber, Sonja I van Nes, et al.
Journal of Neurology|February 25, 2026
Measurement properties of the Inflammatory Rasch-built Overall Disability Scale (I-RODS) in patients with Guillain-Barré syndromeFarah Pelouto, Nowshin Papri, Juanita A Haagsma, et al.
Journal of the Peripheral Nervous System : JPNS|April 12, 2023
IgM anti-MAG<sup>±</sup> peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M-protein peripheral neuropathiesTatiana Hamadeh, Perry T C van Doormaal, Mariëlle H J Pruppers, et al.
Pageof 10